The document discusses HIV infection and encephalitis. Some key points:
- HIV is a retrovirus that causes AIDS and can affect the nervous system directly or indirectly through opportunistic infections.
- Neurological features develop in 80% of infected individuals, manifesting as effects of HIV or infections/tumors due to immunodeficiency.
- HIV encephalitis refers to cognitive impairment from cerebral HIV infection and does not include opportunistic infections from immunodeficiency.
- Symptoms of HIV encephalitis include decreased cognition, psychomotor slowing, and motor symptoms like gait instability. Diagnosis involves neuropsychological testing and neuroimaging. Treatment includes antiretroviral therapy and
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
HIV Encephalitis: Causes, Symptoms and Treatment
1. HIV INFECTION - ENCEPHALITIS
Mrs. M. Pradeepa MPT (Neuro)
Vice Principal
PPG College of Physiotherapy
Coimbatore, Tamilnadu, India
2. INTRODUCTION
• The human immunodeficiency virus (HIV) is an
enveloped retrovirus that contains 2 copies of a
single-stranded RNA genome. It causes the acquired
immunodeficiency syndrome (AIDS) that is the last
stage of HIV disease.
• AIDS was first clinically observed in 1981 in the
United States.
• Both HIV-1 and HIV-2 are believed to have
originated in non-human primates in West-central
Africa, and are believed to have transferred to
humans a process known as zoonosis in the early
20th century
3. HIV AND NERVOUS SYSTEM EFFECTS
• Direct Or Primary Effect
• HIV virus and its products
• Indirect or Secondary Effect
• Opportunistic infection
• HIV associated neoplasms
4. HIV AND CNS
• Neurological features develop in 80% of infected
individuals manifesting as either direct effects of
the HIV virus or infections, tumours and
associated vascular disorders due to
immunodeficiency.
• In a minority of patients, CNS HIV-1 infection
evolves into encephalitis during the late stages of
systemic infection, which compromises brain
function and presents clinically as acquired
immunodeficiency syndrome dementia complex
(ADC)
5. HIV AND CNS
• Potential site of involvement:
• Meninges
• Brain
• Spinal cord
• Cranial and spinal nerves
• ANS
• Muscle
7. DEFINITION
• HIV encephalitis refers to cognitive impairment
resulting from productive cerebral infection by
the human immunodeficiency virus
• It does not apply to opportunistic infections
resulting from generalized cell mediated
immunodeficiency
8. TERMINOLOGY
• Severe cognitive impairment related to HIV
encephalitis was also referred to as HIV
associated dementia (HAD) or the AIDS
dementia complex
• Currently, other terms used to describe this
illness include HIV associated neurocognitive
disorder (HAND) and HIV associated
neurocognitive impairment
9. EPIDEMIOLOGY
• Prevalence estimates for HIV associated
neurocognitive disorder range from 35 to 100%
• Upto 50% of HIV patients have clinically apparent
neurological disease.
• Upto 20% of HIV patients present for the first time
with neurological manifestations.
• Upto 90% of HIV patients have neuropathological
changes on autopsy.
• India has the second largest burden of HIV related
pathology next to sub-Saharan Africa.
• Neurological complications associated to HIV-1
infections, are very common in our clinical setting.
10. TYPES
• HIV neurocognitive impairment be divided into:
• Type I - corresponding to neurocognitive
disability resulting from active HIV encephalitis
• Type II - corresponding to mild cognitive
impairment, for which the neuropathological
substrate has not been established
11. SITES
• Although HIV encephalitis may occur anywhere
within the nervous system, there is a distinct
predilection for pathologic changes to be found
predominantly within subcortical white
matter and basal ganglia
12. PATHOPHYSIOLOGY
• HIV enters the CNS by a mechanism called “Trojan horse” that
consists of the migration of infected monocytes through the BBB.
• Infected monocytes then fuse with resident microglial cells,
perivascular macrophages and potentially adult neural precursors
• Viral replication is also seen in a restrictive manner in astrocytes
• This results in direct and indirect effects of HIV infection will lead to
neuronal dysfunction
• DE: Infected astrocytes and microglia release factors inducing
neurotoxicity such as cytokines, chemokine and reactive oxygen
species (ROS).
• IE: This may also contribute to the disruption of the BBB and result
in further entry/exit of virions and viral proteins
• In addition, HIV associated glycoproteins may interfere with
synaptic activity
• However, neurons are not productively infected by the virus
13.
14. CLINICAL PRESENTATION
• Symptoms may develop over weeks to months
• Cognition:
• Decreased concentration
• Forgetfulness particularly daily or recent events
• Slowing of thought process
• Global dementia
• Psychomotor slowing: verbal response delayed, near
or absolute mutism, vacant stare
• Unwareness of illness or disinhibition
• Confusion, disorientation
• Organic psychosis
15. CLINICAL PRESENTATION
• Motor symptoms:
• Poor balance
• Gait instability – slow and rigid gait
• Slowness of movements
• Tremors
• Other involuntary movements – choreoathetoid
movements
• Myoclonic jerks
• Bladder and bowel incontinence
16. DIAGNOSIS
• Currently, the diagnosis is made through the neuropsychometric
performance testing, in combination with neuroimaging
• Laboratory
• Classical HIV disease biomarkers (low CD4 count, high viral load)
are no longer closely associated with neurological impairment
although markers of systemic inflammation appear to correlate with
cognitive impairment
• ELISA test, Saliva test, Viral load test, Western blot test (HIV tests)
• Radiology description
• Increased white matter signal on fluid level attenuated inversion
recovery (FLAIR) images although these are only apparent in the
more advanced stages of cognitive impairment
• Symmetric patchy periventricular regions
18. DIFFERENTIAL DIAGNOSIS
• Superimposed opportunistic infections or
neoplasms - the presence of subcortical
microglial nodule encephalitis with
multinucleated microglial cells is virtually
pathognomonic for HIV encephalitis
19. MANAGEMENT
• Although implementation of combined
antiretroviral therapy has reduced the
prevalence of severe neurocognitive impairment,
optimized HIV therapy is not sufficient to avert
cognitive impairment
• It is believed that in addition to combined
antiretroviral therapy, treatments that
will address inflammation and
cardiovascular risks may provide benefit
20. MANAGEMENT
• HAART (Highly active antiretroviral therapy)
management comprises two nucleoside reverse
transcriptase inhibitors (e.g. zidovudine and
didanosine) and a protease inhibitor (e.g.
ritonavir or indinavir), or a nonnucleoside
reverse transcriptase inhibitor (nevirapine).
• Opportunistic infection – treatment of specific
infection